Comparative Pharmacognostic Study of Different Parts of Withania somnifera and its Substitute...

Luxmini. K.P.A.M.K, Dharmadasa. R.M, Samarasinghe, K. Muthukumarana. P.R.M

  Open Access OPEN ACCESS  Peer Reviewed PEER-REVIEWED

Comparative Pharmacognostic Study of Different Parts of Withania somnifera and its Substitute Ruellia tuberosa

Luxmini. K.P.A.M.K1, Dharmadasa. R.M1,, Samarasinghe1, K. Muthukumarana. P.R.M1

1Herbal Technology Section, Industrial Technology Institute, 363, Bauddhaloka Mawatha, Colombo 7, Sri Lanka

Abstract

Withania somnifera (L.) Dunal. (Solanaceae) is a therapeutically important medicinal plant widely used in Ayurveda and traditional systems of medicine in all over the world. Since this valuable plant is not commercially cultivated in Sri Lanka, traditional practitioners use Ruellia tuberosa L. (Acanthaceae) as a substitute for Withania somnifera. However, use of R. tuberosa as a substitute without scientifically proven data on important quality standards might adversely affect on the therapeutic properties of herbal drugs. Present study investigates the important pharmacognostic aspects of W. somnifera and R. tuberosa. Comparative quality parameters on morphological, anatomical, powder microscopical, phytochemical, physicochemical and brine shrimp toxicity of different parts of (leaf, bark and roots) W. somnifera and R. tuberosa by using established protocols. Results demonstrated that all major phytochemical groups tested were present in leaves, bark and roots of both plants. Physicochemical analysis exhibited the higher total ash, water soluble ash and acid insoluble ash in all parts of R. tuberosa. However, TLC profiles exhibited the higher number of spots in all 3 parts for W. somnifera over R. tuberosa. Potent of brine shrimp toxicity was increased as leaf>bark>roots for R. tuberosa and bark>root>leaf for Withania somnifera. Therefore, W. somnifer acould be differentiated from R. tuberosaby comparing polymorphic macroscopic, microscopic, phytochemical, physicochemical characters either singularly or as a whole. The presence of certain similarities in major phytochemical groups, and in brine shrimp toxicity of W. somnifera and R. tuberosa partially justifies the use of R. tuberosa as a substitute for W. somnifera in traditional systems of medicine in Sri Lanka which needs to be confirmed after further clinical trials.

At a glance: Figures

Cite this article:

  • K.P.A.M.K, Luxmini., et al. "Comparative Pharmacognostic Study of Different Parts of Withania somnifera and its Substitute Ruellia tuberosa." World Journal of Agricultural Research 3.1 (2015): 28-33.
  • K.P.A.M.K, L. , R.M, D. , Samarasinghe. , & P.R.M, K. M. (2015). Comparative Pharmacognostic Study of Different Parts of Withania somnifera and its Substitute Ruellia tuberosa. World Journal of Agricultural Research, 3(1), 28-33.
  • K.P.A.M.K, Luxmini., Dharmadasa. R.M, Samarasinghe, and K. Muthukumarana. P.R.M. "Comparative Pharmacognostic Study of Different Parts of Withania somnifera and its Substitute Ruellia tuberosa." World Journal of Agricultural Research 3, no. 1 (2015): 28-33.

Import into BibTeX Import into EndNote Import into RefMan Import into RefWorks

1. Introduction

Pharmacognosy is the study of the physical, chemical, biochemical and biological properties of drugs, drug substances or potential drugs or drug substances of natural origin. Study of pharmacognosy is a reliable tool, by which complete information of the crude drug could be obtained [1]. With respect to quality control, correct identification of the species concerned from commonly available adulterants or substitutes, in fresh, dried or powdered state is of prime importance [2]. The process of standardization could be achieved by pharmacognostic studies which help in identification and authentication of the plant materials [3, 4]. Since adulterants or substitutes closely resemble the genuine material, macroscopic or microscopic evidences alone could not always provide evidence for complete identification. On the other hand misidentification of species and the subsequent substitution with adulterated materials reported a real danger in Chinese Traditional Medicine [5, 6]. Therefore, implementation of rigorous standardization process with multi-techniques procedure is required for proper standardization in order to avoid harmful adulteration, substitution, contamination and degradation [7].

Withania somnifera (L.) Dual (Solanaceae) is a therapeutically important, widely used medicinal plant in traditional and Ayurveda systems of medicine for the treatment of mental health, tumor, genotoxicity, arthritis, hypertension, tremors, diabetes, general debility, and angiogenesis activities and maintain the vigour and stamina [8-13][8]. Further, W. somniferais well known for its other biological activities like adapt genic/anti-stress [14, 15], immunomodulatory [16, 17], anti-ageing [14, 15, 18, 19], anti-fatigue [10, 14, 15], antioxidant [18, 20], anti-parkinsonism [21, 22], antiulcerogenic [15-23][15], support healthy thyroid function [24]. Since there is no commercial cultivation of W. somnifera in Sri Lanka, traditional practitioners widely used Ruellia tuberosa L. (Acanthaceae), as a cheap substitute for W. somnifera, which is traditionally used for diuretic, anti-pyretic, analgesic, anti-hypertensive and anthelmintic properties [25]. However, use of R. tuberosa as a substitute without scientifically proven data on important quality standards might adversely affect the therapeutic properties of herbal drug which incorporate R. tuberosa as a substitute. Moreover, even though, this substitution has been practiced since long times, available information on comparative morphological, powder microscopical, physicochemical, phytochemical and basic toxicological studies using brine shrimp assay of W. somnifera and R. tuberosaare scattered. Therefore, present study was undertaken to compare morphological, powder microscopical, physicochemical, phytochemical and bioactivity of different parts of W. somnifera and R. tuberosa in order to scientifically validate the traditional claims of use of R. tuberosa instead of W. somnifera..

2. Materials and Methods

2.1. Plant Material

Plant materials of Withania somnifera and Ruellia tuberosa were collected from the institutional research plots maintained under similar soil and climatic conditions. Herbarium specimens of both plants were prepared and deposited (HTSMP 19& HTSAP-20) in the institutional herbarium.

2.2. Preparation of Free Hand Sections

Free hand transverse sections of leaf of both plants were prepared using razor blades. Suitable sections were selected and taken through an alcohol series and subsequently strained with 1% safranin in 50% ethanol. Stained material was made into temporary mounts using glycerin.

2.3. Phytochemical Studies
2.3.1. Preparation of Extracts

Coarsely powdered material of each plant part (leaf, bark and root 10 g per each) of both species was separately extracted in 50 mL of methanol by using Soxhlet apparatus. The extract was concentrated at 45°C using rotovapour (BuchiRotavapour, Type-R-114A29 B-480, Switzerland).

2.4. Thin Layer Chromatography

The Thin Layer Chromatography (TLC) was performed as described by Stahl [27] with little modifications. TLC plates (Pre-coated silica gel 60 A, 20 X 20 cm; 0.2 mm thickness) and developed using Cyclohexane: Dichloromethane: Ethyl acetate: Methanol (5:1:4:0.4) as mobile phase. Developed TLC plates were visualized under UV 366 and subsequently after spraying with Vanillin sulphuric acid. Colour and the Rf values of each spot was recorded.

2.5. Qualitative Screening of Phytochemicals

Methanolic extracts of leaf, bark and root extracts of W. somnifera and R. tuberosa samples were screened for the presence of preliminary phytochemicals such as alkaloids, flavonoids, saponins, steroid glycosides and tannins according to the method described by reference [26].

2.6. Determination of Physico-Chemical Parameters
2.6.1. Quantification of Total Ash

Dried materials (2 g) were ignited at 500–600°C until the sample turn into white color. Then the total ash content of ignited sample was determined as methods described in WHO guidelines [5].


2.6.2. Quantification of Water-Soluble Ash

Ignited ash sample was mixed with 25 mL of distilled water and boiled, Then it was filtered using a Whatman ashless filter-paper. Insoluble matter was washed with hot water and ignited for 15 min at 450°C. The residue was allowed to cool in a desiccator for 30 minutes [5].


2.6.3. Quantification of Acid-Insoluble Ash

A crucible containing ash was gently boiled with 25 mL of HCl. Insoluble matter was collected to Whatman ashless filter-paper and washed with hot water until the filtrate become neutral. Then the acid insoluble matter was transferred to original crucible and ignited to a constant weight at 450°C. Then the residue was allowed to cool in a desiccator for 30 minutes [5].


2.6.4. Quantification of Total Extractable Matter

Hot extraction method - Four grams of coarsely powdered samples of leaf, bark and root were separately refluxed with 100 mL of methanol for 1 h. Then the mixture was filtered and total weight was re-adjusted by adding methanol and concentrated in a rotavapour (BuchiRotavapour, Type-R-114A29 B-480, Switzerland) at 45°C. The residue was dried at 105°C for 6 h and allowed to cool for 30 min. [5].


2.6.5. Brine Shrimp Toxicity Assay (BST)

Brine shrimp assay was performed as described by Michael [28] with slight modifications. Artemia salinae ggs were incubated in 500 mL of brine water (35 ppt, pH 7.5) under illumination at 28°C ±2°C for 24 h and larvae were transferred to 12 well plates containing 1 mL of aerated artificial brine water. The extracts of 3 different concentrations (1 ppm, 5 ppm, 20 ppm and 50 ppm) were added into the wells and left for 24 h. artificial brine water was used as the control. The numbers of death larvae were counted under light microscope.


2.6.6. Statistical Analysis

Results of physico-chemical parameters and antioxidant activity were analyzed by general linear model (GLM) ANOVA test followed by Duncan’s Multiple Range Test (DMRT) and presented as means ± SE.

3. Results and Discussion

In the present study attempts were made to compare the important pharmacognostic parameters of Withania somnifera and its common substitute Ruellia tuberosa by means of morphological, anatomical, phytochemical, physicochemical and brine shrimp toxicity. Distinguished morphological characters of Withania somnifera and its common substitute Ruellia tuberosa are demonstrated in Figure 1 and distinguished vegetative and reproductive characters are given in Table 1. As shown in Table 1, growth habit, flower type, plant height, leaf phyllotaxy, petiole length flower color, shape of corolla, type of inflorescence, fruit type and seed color could be considered as distinguished polymorphic morphological characters for differentiation of W. somnifera from R. tuberosa at the plant collection point and in the raw material stage.

Table 1. Morphological characters of Withania somnifera and Ruellia tuberosa

Figure 1. Mature plant of (A) Withania somnifera and (B) Ruellia tuberosa

Distinguished morphological (vegetative and reproductive) characters are key parameters which have been widely used for field species recognition, specially to delimitatetaxonomic ambiguity among species or the populations in the same species [29].

As demonstrated in Figure 2, W. somnifera possess anomocytic stomata and much branched trichomes while R. tuberosa possess diacytic stomata and un-branched trichomes. Further, epidermal trichome frequency, veins, and shape of the stem, were key polymorphic features of leaf powder of W. somnifera and R. tuberosa. These distinguished characters either singularly or as a whole could be easily used for differentiation of raw materials of both plants at the powdered stage. Use of gross morphological, foliar anatomical features such as stomata and trichomes have been well reported for authentication of controversial medicinal plantssuch as Plectranthus hadiensis and Plectranthus amboinicus [30], Munronia pinnata and Andrographis paniculata [31], Senna and Munronia pinnata morphitypes [32] & [31]. Therefore, the results of the present study are in agreement with previous studies.

Figure 2. Line drawings of stomata and trichome types found in Withania somnifera and Ruellia tuberosa. [A= stomata of Ruelia tuberosa; B= stomata of Withania somnnifera; C= unbranched trihcome of Ruellia tuberosa and D=Much branched trichomes of Withania somnifera. [Mag: -10x3x40]

Table 2. Distinguished polymorphic anatomical and powder microscopic characters of Withania somnifera and Ruellia tuberosa

Thin Layer chromatographic profiles of leaf, bark and root extracts of W. Somnifera and R. tuberosa compare and found that numbers of spots are greater in all three parts of W. somnifera over the R. tuberosa. Further, spots with similar Rf values were observed under UV 366 nm (Rf 0.08, 0.15, 0.37, 0.65 and 0.91) and after spraying with Vanillin sulphate (Rf 0.75, 0.85 and 0.87) for leaf extracts of W. somnifera and R. tuberosa 0.85 and 0.87) for leaf extracts of W. somnifera and R. tuberosa.

As shown in Figure 3, prominent, bright purple (Rf 0.90), dark green (Rf 0.78) and greenish colour spots distinguished for Withaniasomnifera while dark yellow spots (Rf 0.49 and 0.96) are characteristics to Ruellia tuberosa root extracts. On the other hand two black colour spots (Rf 0.38 &0.43) are common for root extracts of both plants.

As demonstrated in Table 3, it was revealed that total ash, water soluble ash, acid insoluble ash and hot extraction values were comparatively higher in R. tuberosa over the W. somnifera (Table 3). The order of increase of total ash and water soluble ash was varied as leaf>bark > roots for both plant species. Moreover, the higher extractable matter was reported from hot extraction method for both plant species. This may be due to enhancement of extraction in hot extraction procedure. Observed higher extractable matter content of leaf are in agreement with previous studies [31], which reported the presence of comparatively higher extractable matter content in leaf extracts of A. paniculata

Figure 3. Thin layer chromatographic profile of root extract of Withania somnifera and Ruellia tuberose [WS- Withania somnifera root extract; RT- Ruellia tuberosa root extract]

Table 3. Physicochemical characters of Withania somnnifera and Ruellia tuberosa

Table 4. Comparative phytochemical analyses of different parts of Withania somnnifera and Ruellia tuberosa

Table 5. Brine shrimp toxicity of different parts of Withania somnnifera and Ruellia tuberosa

The therapeutic value of drugs, which are mainly based on herbal materials, depends greatly on the bioactive constituents present in the raw materials. Therefore, use of authentic raw materials with proper bioactive molecules play an important role in efficacy, safety and quality control of drugs. As demonstrated in Table 4, root leaf and bark extracts of W. somnifera and R. tuberosa exhibited the presence of major chemical groups such as alkaloids, flavanoids, saponins, steroid glycosides and tannins in both W. somnifera and R. tuberosa.

Brine shrimp toxicity assay is considered as a simple, inexpensive, and a reliable tool for preliminary screening of cytotoxicity and it has consistent with the correlation with cytotoxicity in plant extracts [33, 34]. Therefore, it is commonly used as a preliminary tool for screening cytotoxicity in plant crude extracts [35]. As demonstrated in Table 4, all parts of W. somifera and. R. tuberosa exhibited mild cytotoxicity. Order of potency of W. somnifera was bark>leaf>root while it was leaf > bark > root for. R. tuberosa. Presence of less cytotoxicity in root is an evidence of safety of root extracts of both plants. This result is in agreement with Prabu et al. [36], who investigated acute and sub-acute oral toxicity of W. somnifera root extracts using rat models and found that there was no any toxic signs up to 2000 mg/kg body weight per day. Further, According to Meyer et al. [33], crude plant extract is toxic (active) if it has an LC50 value of less than 1000 µg/mL while non-toxic (inactive) if it is greater than 1000 µg/mL. On the other hand, presence of slightly higher cytotoxicity in bark and leaf extracts of W. somnifera and R. tuberosa might be due to presence biologically active constituents in leaf and bark extracts. Results of the present study are in agreement with Siriwardane et al., [37], who investigated that the presence of higher content of anticancer potential withaferin A, in leaf and bark extracts of W. somnifera. Moreover, Sharmin et al. [38], which proved the presence of cytotoxicity in leaves of A. oleraceae.

4. Conclusions

Even though the plants belong to two genera and possess different morphological and powder microscopical characters, there are certain similarities in preliminary phytochemical screening, thin layer chromatographic profiles and brine shrimp toxicity of different parts of W. somnifera and R. tuberosa. Presence of certain phytochemical groups, both in preliminary phytochemical and physicochemical screening, thin layer chromatographic profiles, and brine shrimp toxicity partially justifies the traditional claim of use of R. tuberosa as a substitute for W. sominifera in traditional systems of medicine in Sri Lanka. However, further studies on separation and bioactivity guided isolation of active constituents, and clinical trials are needed to confirm the above results. Information gathered through the present study could be directly used for the standardization and quality control of W. somnifera and R. tuberosa as well as to upgrade the Sri Lankan pharmacopeia.

Conflict of Interest

Authors declare that there is no conflate of interests

References

[1]  Gokhale, S.B, Pharmacognosy, 29th ed. NiraliPrakashan. 2009.
In article      
 
[2]  Sprinqfield, E.P., Eagles, P.K. and Scott, G, ‘‘Quality assessment of South African herbal medicines by means of HPLC fingerprinting,’’ J Ethnopharmacol, 101 (1-3). 75-83.2005.
In article      
 
[3]  Thomas, S., Patil, D.A., Patil, A.G. and Chandra, N, ‘‘Pharmacognostic evaluation and physicochemical analysis of Averrhoacarambola L. Fruit,’’ J Herb Med Tox, 2 (2). 51-54. 2008.
In article      
 
[4]  Nisa Raj, R.S. and Radhamany, P.M, ‘‘Pharmacognostic and physicochemical analysis on the leaves of Brunfelsia americana L.,’’ Asian Pacific Journal of Tropical Biomedicine, S305-S307. 2012.
In article      
 
[5]  WHO, ‘‘Quality control methods for herbal matreils’’. 1998.
In article      
 
[6]  Chan, T.Y. and Critchley, J.A, ‘‘Usage and adverse effects of Chinese herbal medicines,’’ Human and Experimental Toxicology, 15 (1). 5-12. 1996.
In article      CrossRefPubMed
 
[7]  Dennis V.C. Awang, ‘‘Standardization of Herbal Medicinal Products,’’ in XXVI IHC-Future for Medicinal and Aromatic Plants. Eds. L.E. Craker et al. Acta Hort. 629, ISHS. 2004.
In article      
 
[8]  Bargagna Mohan, P., Hamza, A., Kim, Y.E.,Ho, Y.K., MorVaknin, N., Wendschlag, N., Liu, J., Evans, R. M., Markovitz, D.M., Zhan, C. G., Kim, K. B. and Mohan, R, ‘‘The Tumor Inhibitor and Antiangiogenic Agent Withaferin A Targets the Intermediate Filament Protein Vimentin,’’ Journal of Chemistry & Biology, 14 (6). 623-634. 2007.
In article      CrossRefPubMed
 
[9]  Anon, ‘‘Withania somnifera,’’ Indian Herbal Pharmacopoeia, IDMA, Mumbai. 2002.
In article      
 
[10]  Singh, B., Saxena, A.K., Chandan, B.K., Gupta, D.K., Bhutani, K.K. and Anand, K.K, ‘‘Adaptogenic activity of anovelwithanolide free aqueous fraction from the roots of Withania somnifera Dunal.,’’ Phytotheropy Research, 15 (4). 311-318. 2001.
In article      CrossRefPubMed
 
[11]  Bhattacharya, S.K, Traditional medicine, Mukhajee, B. (Eds), IBH Publishing Company, New Delhi. 1993.
In article      
 
[12]  Nadkarni, K.M, ‘‘Withania somnifera Dunal-2625,’’ The Indian Materia Medica, 1.1292-1294. 1976.
In article      
 
[13]  Shohat, B., Gitter, S., Abraham, A. and Lavie, D, ‘‘Antitumor activity of Withaferin A (NSC-101088),’’ Cancer Chemotherapy Reports, 51. 271-276. 1967.
In article      PubMed
 
[14]  Singh N., Agarwal A.K., Lata A. and Kohli R.P, ‘‘Evaluation of Adaptogenic properties of Withania somnifera,’’ in Proc Ind Pharmacol Soc. 21. 1976.
In article      
 
[15]  Singh, N., Singh, S.P., Sinha, J.N., Shanker, K. and Kohli, R.P, ‘‘Withania somnifera (Ashwagandha) A rejuvenator herbal drug which enhances survival during stress (An adaptogen),’’ Int. J. Crude Res, 3. 29-35. 1982.
In article      
 
[16]  Singh, N, ‘‘A pharmacoclinical evaluation of some ayurvedic crude plant drugs as antistress agents and their usefulness in some stress diseases of man,’’ Ann Nat AcadInd Med, 2 (1). 14-26. 1986.
In article      
 
[17]  Davis, L. and Kuttan, G, ‘‘Effect of Withania somnifera on cell mediated immune responses in mice,’’ J ExpClin Cancer Res, 21 (4). 585-590. 2002.
In article      PubMed
 
[18]  Bhattacharya, A., Ghosal, S. and Bhattacharya, S.K, ‘‘Antioxidant effect of Withania somnifera glycowithanolides in chronic foodshok stress induced perturbation of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum,’’ J Ethanopharmacol, 74 (1). 1-6. 2001.
In article      CrossRef
 
[19]  Bhattacharya, S., Satyan, K.S. and Ghosal, S, ‘‘Antioxidant activity of glycowithanolides from Withania somnifera,’’ Ind J Exp Biol, 35 (3). 236-239. 1997.
In article      PubMed
 
[20]  Kaur, K., Rani, G., Widodo, N., Nagpal, A., Taira, K., Kaul, S.C. and Wadhva, R, ‘‘Evaluation of the anti proliferative and antioxidative activity of leaf extract from in vivo and in vitro raised Ashwagandha,’’ Food ChemToxicol, 42 (12). 2015-2020. 2004.
In article      CrossRefPubMed
 
[21]  Mohan Kumar, K.P, ‘‘Association of M Dopa with recovery following Ayurveda medication in Parkinson Disease,’’ J Neurol Sci, 176 (2). 124-127. 2000.
In article      CrossRef
 
[22]  Ahmad, M., Saleem, S., Ahmad, A.S., Ansari, M.A., Yusuf, S., Hoda, M.M and Islam, F, ‘‘Neuroprotective effect of Withania somnifera on 6-hydroxydopamine indused Parkinsonism in rat,’’ Hum ExpToxicol, 24 (3).137-147. 2005.
In article      
 
[23]  Singh, N., Agarwal, A.K., Lata, A. and Kohli, R.P, ‘‘Experimental evaluation of 'adaptogenic' properties of Withania somnifera,’’ in 7th Scientific Seminar on Indian Medicine, Institute of Medical Sciences. Varanasi. 4. 1977.
In article      
 
[24]  Panda, S. and Kar, A, ‘‘Withania somnifera and Bauhinia pupurea in the regulation circulating thyroid hormone concentration in female mice,’’ J Ethanopharmacol,’’ 67. 233-239. 1999.
In article      CrossRef
 
[25]  Chothani, D.L., Patel, M.B., Mishra, S.H. and Vaghasia, H.U, ‘‘Review on Ruellia tuberosa (Cracker plant),’’ Pharmacognosy journal, 2 (12). 506-12. 2010.
In article      
 
[26]  Farnsworth, N.R, ‘‘Biological and phytochemical screening of plants,’’ Journal of pharmaceutical sciences, 55 (3). 225-76. 1965.
In article      CrossRef
 
[27]  Stahl, E, ‘‘Thin layer chromatograpphy,’’ In A Laboratory hand book. 2nd ed., Springer international student edition, 854-59. 1969.
In article      
 
[28]  Michael, A.S., Thompson, C.G. and Abramovitz, M, ‘‘Artemia salina as a test organism for a bioassay,’’ Science, 123. 464-464. 1956.
In article      CrossRefPubMed
 
[29]  Dharmadasa, R.M., Hettiarachchi, P.L. and Premakumara, G.A.S, ‘‘Geographical distribution and conservation of a rare medicinal plant Munronia pinnata (wall.) theob. (meliaceae) in Sri Lanka,’’ Bangladesh j. plant taxon, 18 (1). 39-49. 2011.
In article      
 
[30]  Muthukumarana, R. and Dharmadasa, R.M, "Pharmacognostical investigation of Plectranthus hadiensis (Forssk.) Schweinf. ex Sprenger. and Plectranthus amboinicus (Lour.) Spreng." World Journal of Agricultural Research, 2.5. 240-246. 2014.
In article      
 
[31]  Dharmadasa R.M., Samarasinghe K., Adhihetty P. and Hettiarachchi P.L, ‘‘Comparative Pharmacognostic Evaluation of Munronia Pinnata (Wall.) Theob. (Meliaceae) and Its Substitute Andrographis paniculata (Burm.f.) Wall. Ex Nees (Acanthaceae),’’ World journal of agricultural research, 1 (5). 77-81. 2013.
In article      
 
[32]  Ayesa, B., Rahman, M. O. and Begum, ‘‘M.Stomatal and trichome diversity in sennamill from Bangladesh. Bangladesh J. Plant Taxon. 21 (1). 43-51. 2014.
In article      
 
[33]  Meyer, B.N., Ferrigni, N.R., Putnam, J.E., Jacobsen, L.B., Nichols, D.E. and McLaughlin, J.L, ‘‘Brine shrimp: A convenient general bioassay for active plant constituents,’’ Plant Med, 45. 31-34. 1982.
In article      CrossRef
 
[34]  Carballo, J.L., Hernández-Inda, Z.L., Pérez P. and García-Grávalos, M.D, ‘‘A comparison between two brine shrimp assays to detect in vitro cytotoxicity in marine natural products,’’ BMC Biotechol, 2. 17. 2002.
In article      CrossRefPubMed
 
[35]  Vivas, L., Easton, A., Kendrick, H., Cameron, A. and Lavandera, J.L, ‘‘Plasmodium falciparum: Stage specific effects of a selective inhibitor of lactate dehydrogenase,’’ Exp. Parasitol,111. 105-114. 2005.
In article      CrossRefPubMed
 
[36]  Prabu, P.C., Panchapakesan, S. and Raj, C.D, ‘‘ Phytother Res, 1169-78. 2013.
In article      CrossRefPubMed
 
[37]  Siriwardane, A.S., Dharmadasa, R.M., and Samarasinghe, K, ‘‘Distribution of withaferin A, an anticancer Potential agent, in different parts of two varities of Withania somnifera (L.) Dunal. grown in Sri Lanka,’’ Pakistan journal of biological sciences, 16 (3). 141-44. 2013.
In article      CrossRefPubMed
 
[38]  Sharmin, T., Islam, F., Kaisar, M.A., Uddin, M.G. and Rashid, M.A, ‘‘Antioxidant, thrombolytic and cytotoxic activities of Picrasma javanica,’’ Dhaka University Journal of Pharmaceutical Science, 11.71-74. 2012.
In article      
 
  • CiteULikeCiteULike
  • MendeleyMendeley
  • StumbleUponStumbleUpon
  • Add to DeliciousDelicious
  • FacebookFacebook
  • TwitterTwitter
  • LinkedInLinkedIn